BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
3/26/2025 10:16:44 AM | Browse: 204 | Download: 814
Publication Name World Journal of Clinical Oncology
Manuscript ID 105077
Country Japan
ISSN 2218-4333 (online)
Open Access This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/Licenses/by-nc/4.0/
Copyright © The Author(s) 2025. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website http://www.wjgnet.com
Category Oncology
Manuscript Type Case Report
Article Title Oxaliplatin-induced diffuse alveolar hemorrhage: A case report
Manuscript Source Unsolicited Manuscript
All Author List Toshiaki Tsurui, Emiko Mura, Atsushi Horiike and Takuya Tsunoda
ORCID
Author(s) ORCID Number
Toshiaki Tsurui http://orcid.org/0000-0002-6167-8953
Takuya Tsunoda http://orcid.org/0000-0002-6416-8211
Funding Agency and Grant Number
Corresponding Author Toshiaki Tsurui, MD, Division of Medical Oncology, Department of Medicine, Showa University School of Medicine, 1-5-8, Hatanodai, Shinagawa-ku, Tokyo 1428555, Tōkyō, Japan. t.tsurui@med.showa-u.ac.jp
Key Words Diffuse alveolar hemorrhage; Oxaliplatin; Esophageal neoplasms; Lung injury; Drug therapy; Case report
Core Tip This report describes a case of a serious complication of oxaliplatin-induced diffuse alveolar hemorrhage. The diagnosis of diffuse alveolar hemorrhage (DAH) is challenging because the clinical manifestations and radiographic findings of DAH, such as diffuse bilateral opacities, are non-specific, necessitating bronchoscopy with bronchoalveolar lavage fluid analysis to establish the diagnosis of DAH. As early diagnosis by bronchoscopy and prompt initiation of corticosteroid treatment were essential for saving the patient, clinicians should be aware that diffuse alveolar hemorrhage is a potential cause of respiratory failure in patients receiving oxaliplatin.
Publish Date 2025-03-26 10:16
Citation

Tsurui T, Mura E, Horiike A, Tsunoda T. Oxaliplatin-induced diffuse alveolar hemorrhage: A case report. World J Clin Oncol 2025; 16(4): 105077

URL https://www.wjgnet.com/2218-4333/full/v16/i4/105077.htm
DOI https://dx.doi.org/10.5306/wjco.v16.i4.105077
Full Article (PDF) WJCO-16-105077-with-cover.pdf